Skip to content
Bomb Report – Lifestyle
Author:
Candel Therapeutics
Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer
April 29, 2026
←
Previous Page
1
2
3